Shire plc Shire Plc : Director/Pdmr Shareholding

TIDMSHP 
 
 
   Director/PDMR 
   Shareholding 
 
 
 
   February 15, 2018 
 
   - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") 
 
 
 
   Notification of transactions by person discharging managerial 
responsibilities 
 
 
 
 
 
     Details of the person discharging managerial responsibilities 
1.    ("PDMR") / person closely associated them ("PCA") 
a)   Name                     Flemming Ornskov, MD, MPH 
2.   Reason for the notification 
a)   Position / status        Chief Executive Officer - PDMR 
     Initial notification / 
b)   amendment                Initial notification 
     Details of the issuer, emission allowance participant, 
3.    auction platform, auctioneer or auction monitor 
a)   Name                     Shire plc 
b)   LEI                      54930005LQRLI2UXRQ59 
     Details of the transaction(s): section to be repeated 
      for (i) each type of instrument; (ii) each type of 
      transaction; (iii) each date; and (iv) each place 
4.    where transactions have been conducted 
     Description of the 
     financial instrument, 
a)   type of instrument       Shire plc American Depositary Shares ("ADSs") 
     Identification code      ISIN: US82481R1068 
                              Release of ADSs awarded under the Shire Executive 
                               Annual Incentive on February 13, 2015. In accordance 
                               with the relevant plan rules, upon release the number 
                               of ADSs to be delivered was increased by an amount 
                               equivalent to the value of dividends paid by the Company 
                               in respect of the ADSs from the award date to the 
                               date of release. 
     Nature of the             (Details of related disposals of ADSs are referenced 
b)   transaction               in section 5. below.) 
c)   Price(s) and volume(s)            Price(s)                      Volume(s) 
                                                       $0                           2,546 
     Aggregated information 
      - Aggregated volume 
d)    - Price                                                    N/A (single transaction) 
e)   Date of the transaction                                            February 13, 2018 
     Place of the 
f)   transaction                                                                      N/A 
     Details of the transaction(s): section to be repeated 
      for (i) each type of instrument; (ii) each type of 
      transaction; (iii) each date; and (iv) each place 
5.    where transactions have been conducted 
     Description of the 
     financial instrument, 
a)   type of instrument                     Shire plc American Depositary Shares ("ADSs") 
     Identification code                                               ISIN: US82481R1068 
                                    Automated disposal of ADSs in relation to the release 
                                     of ADSs referenced in section 4. above. The proceeds 
     Nature of the                     of this disposal were used to satisfy personal tax 
b)   transaction                        liabilities arising from the release of the ADSs. 
c)   Price(s) and volume(s)                      Price(s)                       Volume(s) 
                                                  See appendix below 
     Aggregated information 
      - Aggregated volume 
d)    - Price                      Weighted average price                Aggregate volume 
                                                $132.0104                           1,572 
e)   Date of the transaction  February 13, 2018 
f)   Place of the             ARCX / CDRG / CROS / DBAX / EBXL / INET / NITE / NQPX 
      transaction 
 
 
   Appendix 
 
 
 
 
Place of the transaction   Aggregate volume  Weighted average price 
          ARCX                          369               $132.1072 
          CDRG                          200               $131.9800 
          CROS                          200               $131.9800 
          DBAX                          100               $131.9900 
          EBXL                          100               $131.9850 
          INET                          203               $131.9716 
          NITE                          300               $131.9800 
          NQPX                          100               $131.9900 
          Total                       1,572               $132.0104 
 
   Oliver Strawbridge 
 
   Senior Assistant Company Secretary 
 
   For further information please contact: 
 
 
 
 
Investor Relations 
Christoph Brackmann   [e-mail]    [phone] 
Robert Coates         [e-mail]               [phone] 
Sun Kim               [e-mail]                [phone] 
Media 
Lisa Adler            [e-mail]             [phone] 
Katie Joyce           [e-mail]                 [phone] 
 
 
   NOTES TO EDITORS 
 
   About Shire 
 
   Shire is the global leader in serving patients with rare diseases. We 
strive to develop best-in-class therapies across a core of rare disease 
areas including hematology, immunology, genetic diseases, neuroscience, 
and internal medicine with growing therapeutic areas in ophthalmics and 
oncology. Our diversified capabilities enable us to reach patients in 
more than 100 countries who are struggling to live their lives to the 
fullest. 
 
   We feel a strong sense of urgency to address unmet medical needs and 
work tirelessly to improve people's lives with medicines that have a 
meaningful impact on patients and all who support them on their journey. 
 
   www.shire.com 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Shire plc via Globenewswire 
 
 
 
 

(END) Dow Jones Newswires

February 15, 2018 07:15 ET (12:15 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.